ClinicalTrials.gov record
Recruiting Early Phase 1 Interventional

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

ClinicalTrials.gov ID: NCT06281756

Public ClinicalTrials.gov record NCT06281756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial

Study identification

NCT ID
NCT06281756
Recruitment status
Recruiting
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Milton S. Hershey Medical Center
Other
Enrollment
600 participants

Conditions and interventions

Interventions

  • Cognitive Behavioral Treatment for Insomnia (CBT-I) Behavioral
  • Placebo Other
  • Trazodone Drug

Behavioral · Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 19, 2024
Primary completion
Nov 29, 2027
Completion
May 30, 2028
Last update posted
Nov 9, 2025

2024 – 2028

United States locations

U.S. sites
3
U.S. states
2
U.S. cities
3
Facility City State ZIP Site status
National Jewish Health Denver Colorado 80206-2761 Recruiting
Penn State University Hershey Pennsylvania 17033 Recruiting
University of Pittsburgh Pittsburgh Pennsylvania 15213-3203 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06281756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06281756 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →